SEC Form 4 · accession 0000899243-18-029592
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam D. George
Officer — Secretary
Period of report
Nov 21, 2018
Accepted (ET)
Nov 23, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Nov 21, 2018 | M | 10,000 | $0.0013 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2,F3 | $0.0013 | Nov 21, 2018 | M | 10,000 | D | — | Nov 26, 2018 | Ordinary Shares | 10,000 | 0 | D |
Explanation of responses
- F1Exercise of stock options.
- F2Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.2839 U.S. Dollars as of November 16, 2018.
- F3Granted pursuant to the Issuer's Enterprise Management Incentive Scheme and fully vested.